Clincosm LogoSign in Get a demo

Thyroid Eye Disease

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Thyroid Eye Disease Trial (Satralizumab, Placebo)

Not yet recruiting
  • Thyroid Eye Disease
  • (no location specified)
Oct 25, 2023

Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)

Recruiting
  • Thyroid Eye Disease
  • TOUR006 - 20 MG
  • +2 more
  • Miami, Florida
    Site - 0103
Oct 11, 2023

Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

Not yet recruiting
  • Thyroid Eye Disease
  • VRDN-001 10 mg/kg Drug:
  • (no location specified)
Sep 7, 2023

Thyroid Eye Disease Trial (Satralizumab, Placebo)

Not yet recruiting
  • Thyroid Eye Disease
  • (no location specified)
Aug 4, 2023

Thyroid Eye Disease Trial in Shanghai (IBI311, )

Recruiting
  • Thyroid Eye Disease
  • IBI311
  • placebo
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital, Shanghai JiaoTong University S
Mar 20, 2023

Thyroid Eye Disease Trial in Beijing (ZB001 for injection)

Not yet recruiting
  • Thyroid Eye Disease
  • ZB001 for injection
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Mar 7, 2023

Clinical Activity of TAO Using Periocular Images Taken by

Completed
  • Thyroid Eye Disease
  • taking periorbital selfie images using smartphones
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Feb 15, 2023

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Beverly Hills, California
  • +22 more
Jan 30, 2023

Thyroid Eye Disease Trial in Worldwide (Teprotumumab, Placebo)

Recruiting
  • Thyroid Eye Disease
  • Los Angeles, California
  • +28 more
Jan 19, 2023

Thyroid Eye Disease Trial in Beverly Hills, Jacksonville (VB421, Placebo)

Recruiting
  • Thyroid Eye Disease
  • Beverly Hills, California
  • +1 more
Jan 12, 2023

Customized Multiple Orbital Wall Decompression for

Recruiting
  • Thyroid Eye Disease
  • Modified multiple orbital wall decompression
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Nov 17, 2022

Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease Trial in United States (TEPEZZA, Placebo)

Active, not recruiting
  • Thyroid Eye Disease
  • Chronic (Inactive) Thyroid Eye Disease
  • TEPEZZA
  • Placebo
  • Beverly Hills, California
  • +11 more
Nov 4, 2022

Thyroid Eye Disease Trial in United States (VRDN-001, Placebo)

Recruiting
  • Thyroid Eye Disease
  • Beverly Hills, California
  • +16 more
Aug 11, 2022

Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)

Recruiting
  • Thyroid Eye Disease
  • Graves Orbitopathy
  • Essen, Germany
  • +6 more
Jul 14, 2022

Thyroid Eye Disease, Eyelid Diseases Trial in Tel Hashomer (Tamsulosin)

Recruiting
  • Thyroid Eye Disease
  • Eyelid Diseases
  • Tel Hashomer, Israel
    Sheba Medical Center
Jun 22, 2022

Thyroid Eye Disease Trial in Boston (Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon

Recruiting
  • Thyroid Eye Disease
  • Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
  • +2 more
  • Boston, Massachusetts
    Mass Eye and Ear
Feb 8, 2022

AS-OCT of the Cornea in Thyroid Diseases

Enrolling by invitation
  • Thyroid Eye Disease
  • AS-OCT
  • Minya, Egypt
  • +1 more
Feb 14, 2022

Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)

Completed
Has Results
  • Thyroid Eye Disease
  • Graves' Orbitopathy
  • Teprotumumab
  • Placebo
  • Beverly Hills, California
  • +13 more
Jan 31, 2022

Thyroid Eye Disease Trial in Tehran (drug, dietary supplement, other)

Withdrawn
  • Thyroid Eye Disease
  • Tehran, Iran, Islamic Republic of
    Rassoul Akram Hospital
Dec 18, 2021

Thyroid Eye Disease Trial in Tehran (Methylprednisolone + ASTED, Methylprednisolone +Placebo)

Withdrawn
  • Thyroid Eye Disease
  • Methylprednisolone + ASTED
  • Methylprednisolone +Placebo
  • Tehran, Iran, Islamic Republic of
  • +1 more
Dec 18, 2021

Thyroid Eye Disease Trial in Germany, Italy, United States (Teprotumumab)

Completed
Has Results
  • Thyroid Eye Disease
  • Teprotumumab
  • Beverly Hills, California
  • +12 more
Dec 9, 2021

Thyroid Eye Disease Trial in Los Angeles (Hyaluronic Acid Gel injection, Saline injection)

Terminated
  • Thyroid Eye Disease
  • Hyaluronic Acid Gel injection
  • Saline injection
  • Los Angeles, California
  • +1 more
Sep 27, 2021

High Dose Prednisolone Pharmacokinetics in Acute and Chronic

Not yet recruiting
  • Thyroid Eye Disease
  • +4 more
  • No intervention - prednisolone is taken as part if routine clinical care.
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Aug 11, 2021

Thyroid Eye Disease Trial (peri-levator betamethasone injection, peri-levator triamcinolone injection, peri-levator and

Not yet recruiting
  • Thyroid Eye Disease
  • peri-levator betamethasone injection
  • +3 more
  • (no location specified)
Jul 15, 2021